Literature DB >> 27370646

Knocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells.

Alexandra Iulia Irimie1, Cornelia Braicu2, Valentina Pileczki3,4, Bobe Petrushev3,5, Olga Soritau5, Radu Septimiu Campian6, Ioana Berindan-Neagoe7,8,9.   

Abstract

Oral squamous cell carcinoma (OSCC) is a malignancy with elevated prevalence and somber prognosis due to the fact that most of the patients are diagnosed at an advanced stage. p53 has a crucial role in proliferation and apoptosis during the occurrence and development of numerous malignant tumors. The impact of mutated p53 on the development and progression of OSCC is unclear and might have therapeutic implications. Using an in vitro RNA interference experiment, we have evaluated the impact of p53 knockdown on cell viability, apoptosis, migration, and gene expression for key genes involved in apoptosis and angiogenesis. We observed that inhibiting the expression of p53 decreased the proliferation ability and induced apoptosis/autophagy in SSC-4 cells. Moreover, we observed that this has decreased migration and has blocked the expression of VEGF. In conclusion, our research provides a proof that a direct connection between p53 knockdown and OSCC cell death can be established, therefore opening new potential directions in OSCC molecular therapeutics and management.

Entities:  

Keywords:  Apoptosis; Autophagy; Migration; Oral squamous cell carcinoma; SSC-4 cells; p53 siRNA

Mesh:

Substances:

Year:  2016        PMID: 27370646     DOI: 10.1007/s11010-016-2751-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  46 in total

1.  Platelet-derived growth factor type BB and collagen matrix for soft tissue reconstruction after muco-epidermoid carcinoma removal: a possible therapeutic option.

Authors:  Marco Cicciù; Alan Scott Herford; Vecchio Giada Maria; Ennio Bramanti
Journal:  J Cancer Res Ther       Date:  2015 Jan-Mar       Impact factor: 1.805

2.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  p53 represses autophagy in a cell cycle-dependent fashion.

Authors:  Ezgi Tasdemir; Maria Chiara Maiuri; Idil Orhon; Oliver Kepp; Eugenia Morselli; Alfredo Criollo; Guido Kroemer
Journal:  Cell Cycle       Date:  2008-10-30       Impact factor: 4.534

4.  Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.

Authors:  G Bradley; J Irish; C MacMillan; K Mancer; I Witterick; W Hartwick; P Gullane; S Kamel-Reid; S Benchimol
Journal:  Oncogene       Date:  2001-02-01       Impact factor: 9.867

Review 5.  Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

6.  Immunohistochemical expression of MMP-9 and VEGF in squamous cell carcinoma of the tongue.

Authors:  Aguida Cristina G Henriques; Felipe R de Matos; Hébel C Galvão; Roseana de A Freitas
Journal:  J Oral Sci       Date:  2012-03       Impact factor: 1.556

7.  Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.

Authors:  M Kano; K Matsushita; B Rahmutulla; S Yamada; H Shimada; S Kubo; T Hiwasa; H Matsubara; F Nomura
Journal:  Gene Ther       Date:  2015-08-04       Impact factor: 5.250

8.  The pro-survival role of autophagy depends on Bcl-2 under nutrition stress conditions.

Authors:  Hai-Dong Xu; Dan Wu; Jin-Hua Gu; Jian-Bin Ge; Jun-Chao Wu; Rong Han; Zhong-Qin Liang; Zheng-Hong Qin
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

Review 9.  The rebel angel: mutant p53 as the driving oncogene in breast cancer.

Authors:  Dawid Walerych; Marco Napoli; Licio Collavin; Giannino Del Sal
Journal:  Carcinogenesis       Date:  2012-07-20       Impact factor: 4.944

Review 10.  Targeting Oncogenic Mutant p53 for Cancer Therapy.

Authors:  Alejandro Parrales; Tomoo Iwakuma
Journal:  Front Oncol       Date:  2015-12-21       Impact factor: 6.244

View more
  10 in total

Review 1.  The new era of nanotechnology, an alternative to change cancer treatment.

Authors:  Ancuta Jurj; Cornelia Braicu; Laura-Ancuta Pop; Ciprian Tomuleasa; Claudia Diana Gherman; Ioana Berindan-Neagoe
Journal:  Drug Des Devel Ther       Date:  2017-09-27       Impact factor: 4.162

Review 2.  Current Insights into Oral Cancer Epigenetics.

Authors:  Alexandra Iulia Irimie; Cristina Ciocan; Diana Gulei; Nikolay Mehterov; Atanas G Atanasov; Diana Dudea; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

Review 3.  Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer.

Authors:  Liviuta Budisan; Diana Gulei; Oana Mihaela Zanoaga; Alexandra Iulia Irimie; Chira Sergiu; Cornelia Braicu; Claudia Diana Gherman; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

Review 4.  The Unforeseen Non-Coding RNAs in Head and Neck Cancer.

Authors:  Alexandra Iulia Irimie; Alina-Andreea Zimta; Cristina Ciocan; Nikolay Mehterov; Diana Dudea; Cornelia Braicu; Ioana Berindan-Neagoe
Journal:  Genes (Basel)       Date:  2018-03-01       Impact factor: 4.096

Review 5.  RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.

Authors:  Smaranda Buduru; Alina-Andreea Zimta; Cristina Ciocan; Cornelia Braicu; Diana Dudea; Alexandra Iulia Irimie; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2018-06-08

6.  Premature senescence activation in DLD-1 colorectal cancer cells through adjuvant therapy to induce a miRNA profile modulating cellular death.

Authors:  Sergiu Chira; Lajos Raduly; Cornelia Braicu; Ancuta Jurj; Roxana Cojocneanu-Petric; Laura Pop; Valentina Pileczki; Calin Ionescu; Ioana Berindan-Neagoe
Journal:  Exp Ther Med       Date:  2018-06-19       Impact factor: 2.447

Review 7.  Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era.

Authors:  Alexandra Traila; Patriciu Achimas-Cadariu; Delia Dima; Romeo Micu
Journal:  Cancer Manag Res       Date:  2018-06-13       Impact factor: 3.989

Review 8.  Progress in Research on the Role of Flavonoids in Lung Cancer.

Authors:  Oana Zanoaga; Cornelia Braicu; Ancuta Jurj; Alexandru Rusu; Rares Buiga; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2019-09-02       Impact factor: 5.923

9.  Piwi-Interacting RNA1037 Enhances Chemoresistance and Motility in Human Oral Squamous Cell Carcinoma Cells.

Authors:  Guanghui Li; Xi Wang; Chunmei Li; Shuang Hu; Zhixing Niu; Qiang Sun; Minglei Sun
Journal:  Onco Targets Ther       Date:  2019-12-04       Impact factor: 4.147

10.  The regulation of long non-coding RNA 00958 (LINC00958) for oral squamous cell carcinoma (OSCC) cells death through absent in melanoma 2 (AIM2) depending on microRNA-4306 and Sirtuin1 (SIRT1) in vitro.

Authors:  Lei Jiang; Wenyu Ge; Yifei Cui; Xiaofeng Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.